Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
1978-9-1
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0065-2598
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
101
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
753-64
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:665390-Animals,
pubmed-meshheading:665390-Antigens,
pubmed-meshheading:665390-Cross Reactions,
pubmed-meshheading:665390-Enzymes,
pubmed-meshheading:665390-Erythrocytes,
pubmed-meshheading:665390-Glucuronidase,
pubmed-meshheading:665390-Humans,
pubmed-meshheading:665390-Liposomes,
pubmed-meshheading:665390-Mice
|
pubmed:year |
1978
|
pubmed:articleTitle |
Enzyme therapy XI: immunologic considerations for replacement therapy with unentrapped, erythrocyte- and liposome-entrapped enzymes.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|